An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 168, Issue 4, 2015, Pages 307-315

  Nylocks, K M ^a   Michopoulos, V ^a,b   Rothbaum, A O ^a   Almli, L ^a   Gillespie, C F ^a   Wingo, A ^a   Schwartz, A C ^a   Habib, L ^a   Gamwell, K L ^a   Marvar, P J ^c   Bradley, B ^a,d   Ressler, K J ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c GEORGE WASHINGTON UNIVERSITY   (United States)

^d ATLANTA VA MEDICAL CENTER   (United States)

Author keywords

Angiotensin receptor blockers; Angiotensin converting enzyme inhibitors; PTSD

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ACE PROTEIN, HUMAN; ANGIOTENSIN DERIVATIVE;

ADULT; ARTICLE; BLOOD PRESSURE; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PANIC; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SINGLE NUCLEOTIDE POLYMORPHISM; ANCESTRY GROUP; DEMOGRAPHY; GENETICS; METABOLISM; STRESS DISORDERS, POST-TRAUMATIC;

ADULT; ANGIOTENSIN RECEPTOR ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANGIOTENSINS; CONTINENTAL POPULATION GROUPS; DEMOGRAPHY; FEMALE; HUMANS; MALE; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, SINGLE NUCLEOTIDE; STRESS DISORDERS, POST-TRAUMATIC;

EID: 84929509476     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.32313     Document Type: Article

References (52)

1. Alegria M, Fortuna LR, Lin JY, Norris FH, Gao S, Takeuchi DT, Jackson JS, Shrout P E, Valentine A. 2013. Prevalence, risk, and correlates of posttraumatic stress disorder across ethnic and racial minority groups in the United States. Med Care 51:1114-1123.
2. Almli LM, Mercer KB, Kerley K, Feng H, Bradley B, Conneely KN, Ressler KJ. 2013. ADCYAP1R1 genotype associates with post-traumatic stress symptoms in highly traumatized African-American females. Am J Med Genet B 162B:262-272.
3. APA. American Psychiatric Association. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). 2000.
4. Arias AJ, Gelernter J, Gueorguieva R, Ralevski E, Petrakis IL. 2014. Pharmacogenetics of naltrexone and disulfiram in alcohol dependent, dually diagnosed veterans. Am J Addict 23:288-293.
5. Atlas SA. 2007. The renin-angiotensin aldosterone system: Pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 13:9-20.
6. Baghai TC, Binder EB, Schule C, Salyakina D, Eser D, Lucae S, Zwanzger P, Haberger C, Zill P, Ising M, Deiml T, Uhr M, Illig T, Wichmann HE, Modell S, Nothdurfter C, Holsboer F, Muller-Myhsok B, Moller HJ, Rupprecht R, Bondy B. 2006. Polymorphisms in the angiotensin-converting enzyme gene are associated with unipolar depression, ACE activity and hypercortisolism. Mol Psychiatry 11:1003-1015.
7. Baghai TC, Schule C, Zwanzger P, Minov C, Zill P, Ella R, Eser D, Oezer S, Bondy B, Rupprecht R. 2002. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene. Neurosci Lett 328:299-303.
8. Binder EB, Bradley RG, Liu W, Epstein MP, Deveau TC, Mercer KB, Tang Y, Gillespie CF, Heim CM, Nemeroff CB, Schwartz AC, Cubells JF, Ressler KJ. 2008. Association of FKBP5 polymorphisms and childhood abuse with risk of posttraumatic stress disorder symptoms in adults. Jama 299:1291-1305.
9. Blake DD, Weathers FW, Nagy LM, Kaloupek DG, Gusman FD, Charney DS, Keane T M. 1995. The development of a Clinician-Administered PTSD Scale. J Trauma Stress 8:75-90.
10. Boscarino JA. 1997. Diseases among men 20 years after exposure to severe stress: Implications for clinical research and medical care. Psychosom Med 59:605-614.
11. Boscarino JA. 2004. Posttraumatic stress disorder and physical illness: Results from clinical and epidemiologic studies. Ann N Y Acad Sci 1032:141-153.
12. Boscarino JA, Chang J. 1999. Electrocardiogram abnormalities among men with stress-related psychiatric disorders: Implications for coronary heart disease and clinical research. Ann Behav Med 21:227-234.
13. Boscarino JA, Kirchner HL, Hoffman SN, Erlich PM. 2013. Predicting PTSD using the New York Risk Score with genotype data: potential clinical and research opportunities. Neuropsychiatr Dis Treat 9:517-527.
14. Breslau N. 2001. The epidemiology of posttraumatic stress disorder: What is the extent of the problem? J Clin Psychiatry 62 Suppl 17:16-22.
15. Buckley TC, Kaloupek DG. 2001. A meta-analytic examination of basal cardiovascular activity in posttraumatic stress disorder. Psychosom Med 63:585-594.
16. Coffey SF, Dansky BS, Falsetti SA, Saladin ME, Brady KT. 1998. Screening for PTSD in a substance abuse sample: Psychometric properties of a modified version of the PTSD Symptom Scale Self-Report. Posttraumatic stress disorder. J Trauma Stress 11:393-399.
17. Corrigan A, Walker JL, Wickramasinghe S, Hernandez MA, Newhouse SJ, Folarin AA, Lewis CM, Sanderson JD, Spicer J, Marinaki AM. 2014. Pharmacogenetics of pemetrexed combination therapy in lung cancer: Pathway analysis reveals novel toxicity associations. Pharmacogenomics J. 14(5):411-417. doi: 10.1038/tpj.2014.13. Epub 2014 Apr 15.
18. Dandona P, Kumar V, Aljada A, Ghanim H, Syed T, Hofmayer D, Mohanty P, Tripathy D, Garg R. 2003. Angiotensin II receptor blocker valsartan suppresses reactive oxygen species generation in leukocytes, nuclear factor-kappa B, in mononuclear cells of normal subjects: evidence of an antiinflammatory action. J Clin Endocrinol Metab 88:4496-4501.
19. Edmondson D, Kronish I M, Shaffer JA, Falzon L, Burg MM. 2013. Posttraumatic stress disorder and risk for coronary heart disease: A meta-analytic review. Am Heart J 166:806-814.
20. Erhardt A, Lucae S, Kern N, Unschuld PG, Ising M, Lieb R, Uhr M, Hohoff C, Deckert J, Bandelow B, Maier W, Binder EB, Muller-Myhsok B, Keck ME, Holsboer F. 2008. Association of polymorphisms in the angiotensin-converting enzyme gene with syndromal panic attacks. Mol Psychiatry 13:242-243.
21. Erickson LD, Hedges DW, Call VR, Bair B. 2013. Prevalence of and factors associated with subclinical posttraumatic stress symptoms and PTSD in urban and rural areas of Montana: A cross-sectional study. J Rural Health 29:403-412.
22. Foa EB, Tolin DF. 2000. Comparison of the PTSD symptom scale-interview version and the vlinician-administered PTSD scale. J Trauma Stress 13:181-191.
23. Gillespie CF, Bradley B, Mercer K, Smith AK, Conneely K, Gapen M, Weiss T, Schwartz AC, Cubells JF, Ressler KJ. 2009. Trauma exposure and stress-related disorders in inner city primary care patients. Gen Hosp Psychiatry 31:505-514.
24. Graham DP, Nielsen DA, Kosten TR, Davis LL, Hamner MB, Makotkine I, Yehuda R. 2014. Examining the utility of using genotype and functional biology in a clinical pharmacology trial: Pilot testing dopamine beta-hydroxylase, norepinephrine, and post-traumatic stress disorder. Psychiatr Genet 24:181-182.
25. Holman EA. 2012. Acute stress and cardiovascular health: Is there an ACE gene connection? J Trauma Stress 25:592-597.
26. Kao AC, Rojnic Kuzman M, Tiwari AK, Zivkovic MV, Chowdhury NI, Medved V, Kekin I, Zai CC, Lieberman JA, Meltzer HY, Bozina T, Bozina N, Kennedy JL, Sertic J, Muller DJ. 2014. Methylenetetrahydrofolate reductase gene variants and antipsychotic-induced weight gain and metabolic disturbances. J Psychiatr Res 54:36-42.
27. Kehoe AD, Eleftheriou KI, Heron M, Coats TJ, Montgomery HE. 2008. Angiotensin-converting enzyme genotype may predict survival following major trauma. Emerg Med J 25:759-761.
28. Khoury NM, Marvar PJ, Gillespie CF, Wingo A, Schwartz A, Bradley B, Kramer M, Ressler KJ. 2012. The renin-angiotensin pathway in posttraumatic stress disorder: Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers are associated with fewer traumatic stress symptoms. J Clin Psychiatry 73:849-855.
29. KIBLER JL. 2009. Posttraumatic stress and cardiovascular disease risk. J Trauma Dissociation 10:135-150.
30. Kirsten R, Nelson K, Kirsten D, Heintz B. 1998. Clinical pharmacokinetics of vasodilators. Part I. Clin Pharmacokinet 34:457-482.
31. Koenen KC, Harley R, Lyons MJ, Wolfe J, Simpson JC, Goldberg J, Eisen SA, Tsuang M. 2002. A twin registry study of familial and individual risk factors for trauma exposure and posttraumatic stress disorder. J Nerv Ment Dis 190:209-218.
32. Kubzansky LD, Koenen KC, Spiro A, Vokonas PS. Sparrow D. 2007. Prospective study of posttraumatic stress disorder symptoms and coronary heart disease in the Normative Aging Study. Arch Gen Psychiatry 64:109-116.
33. Kun P, Tong X, Liu Y, Pei X, Luo H. 2013. What are the determinants of post-traumatic stress disorder: Age, gender, ethnicity or other? Evidence from 2008 Wenchuan earthquake. Public Health 127:644-652.
34. Lin S, Zhoa H. 2009. Handbook on analyzing human genetic data: Computational approaches and software. New York: Springer.
35. Marinzalda MDLA, Pérez PA, Gargiulo PA, Casarsa BS, Bregonzio C, Baiardi G. 2014. Fear-Potentiated Behaviour Is Modulated by Central Amygdala Angiotensin II AT1 Receptors Stimulation. BioMed Res Int 18:32-48.
36. Marvar P J, Goodman J, Fuchs S, Choi D C, Banerjee S, Ressler K J. 2014. Angiotensin type 1 receptor inhibition enhances the extinction of fear memory. Biol Psychiatry 75:864-872.
37. Ned RM, Yesupriya A, Imperatore G, Smelser DT, Moonesinghe R, Chang MH, Dowling NF. 2012. The ACE I/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race/ethnicity. Am J Hypertens 25:209-215.
38. Outhred T, Das P, Dobson-Stone C, Felmingham KL, Bryant RA, Nathan PJ, Malhi GS, Kemp AH. 2014. The impact of 5-HTTLPR on acute serotonin transporter blockade by escitalopram on emotion processing: Preliminary findings from a randomised, crossover fMRI study. Aust N Z J Psychiatry. 48(12):1115-1125. doi: 10.1177/0004867414533837. Epub 2014 May 8.
39. Paulus EJ, Argo TR, Egge JA. 2013. The impact of posttraumatic stress disorder on blood pressure and heart rate in a veteran population. J Trauma Stress 26:169-172.
40. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. 2006. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38:904-909.
41. Ressler KJ, Mercer KB, Bradley B, Jovanovic T, Mahan A, Kerley K, Norrholm S D, Kilaru V, Smith AK, Myers AJ, Ramirez M, Engel A, Hammack SE, Toufexis D, Braas KM, Binder EB, May V. 2011. Post-traumatic stress disorder is associated with PACAP and the PAC1 receptor. Nature 470:492-497.
42. Saavedra JM, Sanchez-Lemus E, Benicky J. 2011. Blockade of brain angiotensin II AT1 receptors ameliorates stress, anxiety, brain inflammation and ischemia: Therapeutic implications. Psychoneuroendocrinology 36:1-18.
43. Schwartz AC, Bradley RL, Sexton M, Sherry A, Ressler KJ. 2005. Posttraumatic stress disorder among African Americans in an inner city mental health clinic. Psychiatr Serv 56:212-215.
44. Sharma S, Malarcher AM, Giles WH, Myers G. 2004. Racial, ethnic and socioeconomic disparities in the clustering of cardiovascular disease risk factors. Ethn Dis 14:43-48.
45. Tipps ME, Raybuck JD, Lattal KM. 2014. Substance abuse, memory, and post-traumatic stress disorder. Neurobiol Learn Mem 112C:87-100.
46. True WR, Rice J, Eisen SA, Heath AC, Goldberg J, Lyons MJ, Nowak J. 1993. A twin study of genetic and environmental contributions to liability for posttraumatic stress symptoms. Arch Gen Psychiatry 50:257-264.
47. Turner JH, Neylan TC, Schiller NB, Li Y, Cohen BE. 2013. Objective evidence of myocardial ischemia in patients with posttraumatic stress disorder. Biol Psychiatry 74:861-866.
48. Vaccarino V, Goldberg J, Rooks C, Shah AJ, Veledar E, Faber TL, Votaw JR, Forsberg CW, Bremner JD. & 2013. Post-traumatic stress disorder and incidence of coronary heart disease: A twin study. J Am Coll Cardiol 62:970-978.
49. Wang L, Cao C, Wang R, Qing Y, Zhang J, Zhang XY. 2013. PAC1 receptor (ADCYAP1R1) genotype is associated with PTSD's emotional numbing symptoms in Chinese earthquake survivors. J Affect Disord 150:156-159.
50. Weiss T, Skelton K, Phifer J, Jovanovic T, Gillespie CF, Smith A, Umpierrez G, Bradley B, Ressler KJ. 2011. Posttraumatic stress disorder is a risk factor for metabolic syndrome in an impoverished urban population. Gen Hosp Psychiatry 33:135-142.
51. Whitfield KE, Yao X, Boomer KB, Vogler GP, Hayward MD, Vandenbergh DJ. & 2009. Analysis of candidate genes and hypertension in African American adults. Ethn Dis 19:18-22.
52. Zill P, Baghai TC, Schule C, Born C, Frustuck C, Buttner A, Eisenmenger W, Varallo-Bedarida G, Rupprecht R, Moller HJ, Bondy B. 2012. DNA methylation analysis of the angiotensin converting enzyme (ACE) gene in major depression. PLoS One 7:e40479.